IFF
International Flavors & Fragrances Inc. NYSE Listed Dec 17, 1974$76.72
After hrs
$76.72
+0.00%
Mkt Cap $19.6B
52w Low $59.55
73.2% of range
52w High $83.00
50d MA $74.41
200d MA $69.88
P/E (TTM)
-52.5x
EV/EBITDA
30.5x
P/B
1.4x
Debt/Equity
0.5x
ROE
2.0%
P/FCF
76.7x
RSI (14)
52.10
ATR (14)
$2.09
Beta
1.03
50d MA
$74.41
200d MA
$69.88
Avg Volume
2.1M
International Flavors & Fragrances Inc., together with its subsidiaries, manufactures and sells cosmetic active and natural health ingredients for use in various consumer products in Europe, Africa, the Middle East, Greater Asia, North America, and Latin America. It operates through Nourish, Scent, Health & Biosciences, and Pharma Solutions segments. The Nourish segment offers natural and plant-based specialty food ingredients, such as flavor compounds, and savory solutions and inclusions. It also provides natural food protection ingredients consist of natural antioxidants and anti-microbials as well as beverages, sweets , and dairy products. The Scent segment provides fragrance compounds, which include fine fragrances comprising perfumes and colognes, as well as consumer fragrances; fragrance ingredients comprising synthetic and natural ingredients that could be combined with other materials to create fragrance and consumer compounds; and cosmetic active ingredients consisting of active and functional ingredients, botanicals, and delivery systems to support its customers' cosmetic and personal care product lines. The Health & Biosciences segment develops and produces enzymes, food cultures, probiotics, and specialty ingredients. The Pharma Solutions segment produces and sells cellulosics and seaweed-based pharma excipients. The company sells its products primarily to manufacturers of perfumes and cosmetics, hair and other personal care products, soaps and detergents, cleaning products, dairy, meat and other processed foods, beverages, snacks and savory foods, sweet and baked goods, dietary supplements, infant and elderly nutrition, functional food, and pharmaceutical excipients and oral care products. International Flavors & Fragrances Inc. was founded in 1833 and is headquartered in New York, New York.
521 West 57th Street · New York City, NY 10019-2960 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 5, 2026 | AMC | 1.08 | 0.66 | -38.9% | 70.77 | +14.2% | +17.2% | -5.6% | +3.6% | -2.8% | -0.4% | — |
| Feb 11, 2026 | AMC | 0.83 | 0.80 | -3.4% | 76.97 | +2.5% | +5.9% | +1.8% | -0.3% | +0.3% | -1.6% | — |
| Nov 4, 2025 | AMC | 1.02 | 1.05 | +2.9% | 61.49 | +2.0% | +4.1% | -1.8% | -1.4% | +1.3% | +4.0% | — |
| Aug 5, 2025 | AMC | 1.12 | 1.15 | +2.7% | 70.62 | +4.7% | -6.3% | -2.9% | -1.0% | -0.2% | +1.7% | — |
| May 6, 2025 | AMC | 1.13 | 1.20 | +6.2% | 79.20 | -2.0% | -7.1% | +0.7% | -0.9% | +4.0% | +0.2% | — |
| Feb 18, 2025 | AMC | 0.83 | 0.97 | +16.9% | 86.45 | -6.3% | -5.2% | -2.3% | -0.3% | -0.4% | +0.8% | — |
| Nov 5, 2024 | AMC | 1.07 | 1.04 | -2.8% | 99.10 | -4.1% | -11.6% | +3.9% | +1.5% | -1.2% | -2.0% | — |
| Aug 6, 2024 | AMC | 0.99 | 1.16 | +16.7% | 96.48 | +2.8% | -2.4% | +1.4% | +0.7% | -0.4% | +0.9% | — |
| May 6, 2024 | AMC | 0.86 | 1.13 | +31.7% | 88.66 | +4.4% | +6.4% | +3.1% | -0.2% | +0.1% | -0.7% | — |
| Feb 20, 2024 | AMC | 0.75 | 0.72 | -4.0% | 82.03 | -9.2% | -6.4% | +3.5% | +1.3% | -3.8% | -3.8% | — |
| Nov 6, 2023 | AMC | 0.76 | 0.89 | +17.1% | 72.34 | +7.8% | -1.0% | -0.8% | +0.7% | +0.3% | -0.7% | — |
| Aug 7, 2023 | AMC | 1.10 | 0.86 | -21.8% | 80.34 | -22.0% | -19.4% | -1.5% | -0.8% | +1.6% | +1.1% | — |
| May 8, 2023 | AMC | 0.89 | 0.87 | -2.2% | 97.14 | -3.9% | -7.0% | -3.9% | -1.6% | -2.6% | +1.4% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 22 | Oppenheimer | Maintains | Outperform → Outperform | — | $72.42 | $72.94 | +0.7% | -1.7% | -0.3% | +0.3% | -0.2% | -0.3% |
| Apr 14 | Barclays | Maintains | Overweight → Overweight | — | $71.70 | $71.50 | -0.3% | +1.2% | -1.5% | +0.7% | +5.3% | -1.9% |
| Apr 13 | Citigroup | Maintains | Buy → Buy | — | $72.52 | $71.97 | -0.8% | -1.1% | +1.2% | -1.5% | +0.7% | +5.3% |
| Apr 9 | UBS | Maintains | Neutral → Neutral | — | $73.77 | $72.82 | -1.3% | -0.9% | -0.8% | -1.1% | +1.2% | -1.5% |
| Feb 17 | Mizuho | Maintains | Outperform → Outperform | — | $83.00 | $84.00 | +1.2% | -0.3% | +0.3% | -1.6% | -0.3% | +1.0% |
| Feb 17 | Barclays | Maintains | Overweight → Overweight | — | $83.00 | $84.00 | +1.2% | -0.3% | +0.3% | -1.6% | -0.3% | +1.0% |
| Feb 13 | Wells Fargo | Maintains | Overweight → Overweight | — | $81.50 | $82.50 | +1.2% | +1.8% | -0.3% | +0.3% | -1.6% | -0.3% |
| Feb 13 | Oppenheimer | Upgrade | Perform → Outperform | — | $81.50 | $82.50 | +1.2% | +1.8% | -0.3% | +0.3% | -1.6% | -0.3% |
| Feb 13 | Citigroup | Maintains | Buy → Buy | — | $81.50 | $82.50 | +1.2% | +1.8% | -0.3% | +0.3% | -1.6% | -0.3% |
| Feb 12 | Mizuho | Maintains | Outperform → Outperform | — | $76.97 | $78.88 | +2.5% | +5.9% | +1.8% | -0.3% | +0.3% | -1.6% |
| Jan 22 | Argus | Maintains | Buy → Buy | — | $71.30 | $71.51 | +0.3% | +1.2% | +1.5% | +1.1% | -1.1% | -1.4% |
| Jan 21 | Citigroup | Maintains | Buy → Buy | — | $70.86 | $71.50 | +0.9% | +0.6% | +1.2% | +1.5% | +1.1% | -1.1% |
| Jan 12 | UBS | Maintains | Neutral → Neutral | — | $69.10 | $69.42 | +0.5% | -0.2% | +0.9% | +0.8% | +0.9% | +1.2% |
| Nov 7 | Barclays | Maintains | Overweight → Overweight | — | $62.85 | $63.16 | +0.5% | -1.4% | +1.3% | +4.0% | +0.2% | +3.1% |
| Nov 6 | UBS | Maintains | Neutral → Neutral | — | $64.00 | $64.32 | +0.5% | -1.8% | -1.4% | +1.3% | +4.0% | +0.2% |
| Oct 14 | BofA Securities | Maintains | Buy → Buy | — | $60.10 | $60.00 | -0.2% | +2.6% | +0.4% | +1.1% | +1.8% | +1.4% |
| Oct 7 | Argus | Maintains | Buy → Buy | — | $61.50 | $61.85 | +0.6% | -0.8% | +0.5% | -1.9% | -1.0% | +0.9% |
| Oct 6 | Citigroup | Maintains | Buy → Buy | — | $62.18 | $62.05 | -0.2% | -1.1% | -0.8% | +0.5% | -1.9% | -1.0% |
| Oct 6 | UBS | Maintains | Neutral → Neutral | — | $62.18 | $62.05 | -0.2% | -1.1% | -0.8% | +0.5% | -1.9% | -1.0% |
| Oct 3 | Mizuho | Maintains | Outperform → Outperform | — | $61.51 | $61.35 | -0.3% | +1.1% | -1.1% | -0.8% | +0.5% | -1.9% |
| Sep 22 | Morgan Stanley | Maintains | Overweight → Overweight | — | $63.53 | $63.33 | -0.3% | -2.1% | +0.3% | +0.2% | -3.6% | +0.7% |
| Sep 8 | Wolfe Research | Upgrade | Underperform → Peer Perform | — | $66.03 | $67.03 | +1.5% | +0.2% | -1.7% | -0.9% | +2.9% | -1.1% |
| Aug 26 | Tigress Financial | Maintains | Buy → Buy | — | $67.14 | $67.11 | -0.0% | -0.6% | +0.1% | +0.5% | +0.6% | -1.4% |
| Aug 8 | Barclays | Maintains | Overweight → Overweight | — | $64.23 | $64.50 | +0.4% | -1.0% | -0.2% | +1.7% | +3.1% | -1.2% |
| Aug 7 | Wells Fargo | Maintains | Overweight → Overweight | — | $66.16 | $65.79 | -0.6% | -2.9% | -1.0% | -0.2% | +1.7% | +3.1% |
| Aug 6 | UBS | Maintains | Neutral → Neutral | — | $70.62 | $73.94 | +4.7% | -6.3% | -2.9% | -1.0% | -0.2% | +1.7% |
| May 13 | Morgan Stanley | Maintains | Overweight → Overweight | — | $76.35 | $76.50 | +0.2% | +0.2% | -2.4% | +2.0% | +2.1% | -0.5% |
| May 8 | Citigroup | Maintains | Buy → Buy | — | $73.59 | $74.70 | +1.5% | +0.7% | -0.9% | +4.0% | +0.2% | -2.4% |
| May 8 | Barclays | Upgrade | Equal Weight → Overweight | — | $73.59 | $74.70 | +1.5% | +0.7% | -0.9% | +4.0% | +0.2% | -2.4% |
| May 8 | Baird | Maintains | Outperform → Outperform | — | $73.59 | $74.70 | +1.5% | +0.7% | -0.9% | +4.0% | +0.2% | -2.4% |
| May 7 | UBS | Maintains | Neutral → Neutral | — | $79.20 | $77.59 | -2.0% | -7.1% | +0.7% | -0.9% | +4.0% | +0.2% |
| Apr 22 | Oppenheimer | Maintains | Outperform → Outperform | — | $72.71 | $73.51 | +1.1% | +2.7% | +1.6% | +1.0% | -0.5% | +0.1% |
| Apr 15 | Mizuho | Maintains | Outperform → Outperform | — | $73.48 | $73.14 | -0.5% | -1.3% | -2.0% | +2.0% | +0.3% | +2.7% |
| Apr 14 | Barclays | Maintains | Equal Weight → Equal Weight | — | $73.17 | $73.77 | +0.8% | +0.4% | -1.3% | -2.0% | +2.0% | +0.3% |
| Apr 10 | Morgan Stanley | Maintains | Overweight → Overweight | — | $72.97 | $72.28 | -0.9% | -2.2% | +2.5% | +0.4% | -1.3% | -2.0% |
| Apr 10 | Stifel | Maintains | Buy → Buy | — | $72.97 | $72.28 | -0.9% | -2.2% | +2.5% | +0.4% | -1.3% | -2.0% |
| Apr 9 | Wells Fargo | Maintains | Overweight → Overweight | — | $66.85 | $66.31 | -0.8% | +9.2% | -2.2% | +2.5% | +0.4% | -1.3% |
| Apr 8 | Citigroup | Maintains | Buy → Buy | — | $70.71 | $71.69 | +1.4% | -5.5% | +9.2% | -2.2% | +2.5% | +0.4% |
| Mar 27 | Barclays | Maintains | Equal Weight → Equal Weight | — | $77.66 | $77.69 | +0.0% | +0.7% | -2.2% | +1.5% | -0.2% | +1.5% |
| Feb 20 | Wells Fargo | Maintains | Overweight → Overweight | — | $81.99 | $81.56 | -0.5% | -2.3% | -0.3% | -0.4% | +0.8% | +0.4% |
| Feb 20 | Oppenheimer | Maintains | Outperform → Outperform | — | $81.99 | $81.56 | -0.5% | -2.3% | -0.3% | -0.4% | +0.8% | +0.4% |
| Feb 20 | BofA Securities | Maintains | Buy → Buy | — | $81.99 | $81.56 | -0.5% | -2.3% | -0.3% | -0.4% | +0.8% | +0.4% |
| Feb 20 | JP Morgan | Maintains | Overweight → Overweight | — | $81.99 | $81.56 | -0.5% | -2.3% | -0.3% | -0.4% | +0.8% | +0.4% |
| Feb 3 | Stifel | Maintains | Buy → Buy | — | $87.09 | $85.38 | -2.0% | -0.8% | -0.9% | +0.7% | -0.6% | -1.6% |
| Jan 28 | Oppenheimer | Maintains | Outperform → Outperform | — | $87.63 | $87.36 | -0.3% | -1.2% | -0.6% | +2.0% | -0.7% | -0.8% |
| Jan 17 | Barclays | Maintains | Equal Weight → Equal Weight | — | $84.44 | $84.81 | +0.4% | +0.5% | +0.8% | -0.1% | +1.1% | -0.7% |
| Jan 7 | Argus | Upgrade | Hold → Buy | — | $82.11 | $83.11 | +1.2% | +0.5% | -0.6% | -0.9% | +2.4% | +0.4% |
| Dec 18 | Citigroup | Maintains | Buy → Buy | — | $86.77 | $86.30 | -0.5% | -1.6% | +0.7% | -0.2% | -1.1% | +0.4% |
| Nov 12 | Morgan Stanley | Upgrade | Equal Weight → Overweight | — | $91.21 | $91.64 | +0.5% | -2.0% | +0.5% | -0.5% | -3.6% | +0.5% |
| Nov 7 | Vertical Research | Upgrade | Hold → Buy | — | $87.57 | $88.15 | +0.7% | +3.9% | +1.5% | -1.2% | -2.0% | +0.5% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | FRIBOURG PAUL JDir | — | Buy | 260,000 | $74.28 | $19.3M | 2,682,730 | +0.44% | +4.38% |
| Jun 1, 2026 | FRIBOURG PAUL JDir | — | Buy | 13,500 | $74.49 | $1.0M | 43,150 | +0.44% | +4.38% |
8-K
International Flavors & Fragrances Inc. -- 8-K Filing
Jun 1
8-K
International Flavors & Fragrances Inc. -- 8-K Filing
International Flavors & Fragrances reported Q4 and full-year 2025 earnings results, providing investors with updated financial performance metrics and guidance for assessing the company's operational trajectory.
Feb 11
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Dodge & Cox | 36,472,942 | $2.6B | — | Mar 2026 |
| 2 | Freemont Capital Pte Ltd | 25,356,381 | $1.8B | — | Mar 2026 |
| 3 | First Eagle Investment Management, Llc | 18,629,340 | $1.4B | Added | Mar 2026 |
| 4 | Vanguard Capital Management Llc | 16,238,225 | $1.2B | New | Mar 2026 |
| 5 | Vanguard Portfolio Management Llc | 11,723,231 | $851M | New | Mar 2026 |
| 6 | Invesco Ltd. | 7,492,841 | $544M | — | Mar 2026 |
| 7 | Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main | 5,004,874 | $525M | Added | Sep 2024 |
| 8 | First Pacific Advisors, Lp | 5,409,925 | $392M | Added | Mar 2026 |
| 9 | Morgan Stanley | 5,252,920 | $354M | Added | Dec 2025 |
| 10 | Icahn Carl C | 4,275,000 | $310M | — | Mar 2026 |
| 11 | State Farm Mutual Automobile Insurance Co | 3,821,419 | $277M | — | Mar 2026 |
| 12 | Northern Trust Corp | 2,913,899 | $211M | Added | Mar 2026 |
| 13 | Aqr Capital Management Llc | 2,278,075 | $163M | Reduced | Mar 2026 |
| 14 | Bank Of New York Mellon Corp | 1,598,636 | $116M | Added | Mar 2026 |
| 15 | Franklin Resources Inc | 1,526,170 | $111M | Added | Mar 2026 |
| 16 | Bank Of America Corp /de/ | 1,504,078 | $109M | Reduced | Mar 2026 |
| 17 | Ubs Group Ag | 1,498,654 | $109M | Reduced | Mar 2026 |
| 18 | Jpmorgan Chase & Co | 1,468,991 | $104M | Added | Mar 2026 |
| 19 | Fort Washington Investment Advisors Inc /oh/ | 1,427,599 | $104M | Added | Mar 2026 |
| 20 | Nordea Investment Management Ab | 1,400,208 | $100M | Reduced | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$19.64B
Enterprise Value
$23.79B
P/E (TTM)
-52.55x
Forward P/E
17.49x
PEG Ratio
0.18x
P/B
1.38x
P/S
1.80x
P/FCF
76.72x
EV/EBITDA
30.54x
Shares Out
256.0M
Financials (TTM)
Revenue
$10.89B
Net Income
-$374.0M
EBITDA
$779.0M
Free Cash Flow
$256.0M
Op Cash Flow
$850.0M
EPS Basic
$-1.46
EPS Diluted
$-1.46
EPS Forward
$4.39
Gross Margin
30.9%
Op Margin
9.2%
Net Margin
-3.4%
Balance Sheet
Total Assets
$25.54B
Total Liab.
$11.35B
Total Equity
$14.19B
Cash
$590.0M
LT Debt
$4.74B
Book Value/Sh
$55.41
Debt/Equity
0.47x
Current Ratio
1.42
Quick Ratio
0.82
Returns & Growth
ROE
2.0%
ROA
1.1%
ROIC
3.9%
Rev Growth YoY
-5.2%
EPS Growth YoY
-253.7%
Price Returns
2W
-0.1%
1M
+8.3%
3M
-7.5%
6M
+9.5%
12M
-0.7%
Technicals
52W High
$83.00
52W Low
$59.55
50d MA
$74.41
200d MA
$69.88
RSI (14)
52.10
ATR (14)
$2.09
Beta
1.03
Avg Volume
2.1M
Dividends
Div Rate
$1.60
Div Yield
2.3%
Frequency
4
Ex-Div Date
Mar 20, 2026
Analyst Price Targets
Consensus
$87.75
High
$97.00
Low
$75.00
Median
$91.00
Data updated apr 25, 2026 3:04pm
· Source: financialmodelingprep.com